1AE.F
argenx SE
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
879.00
▲ 9.00 (1.03%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
879.00
Prev close
870.00
Day high
885.80
Day low
879.00
Volume
58
Market cap
$54.66B
P/E (TTM)
39.07
52W range
566.40 – 891.00
Day trading desk
Gap from prior close
+1.03%
Prior close 870.00
VWAP
879.33
-0.04% from price
Relative volume
2.77×
Unusually busy
Session range
0.77%
879.00 – 885.80
Position in range
0%
Near session low
ATR (14D)
22.06
2.51% of price
Prior day high
870.00
PDH
Prior day low
870.00
PDL
Bid / ask spread
—
Quote not published
Session volume
61
Avg 22
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+18.11%
+19.5%
1M
+8.73%
+5.0%
3M
+25.21%
+22.1%
6M
+24.72%
+13.7%
YTD
+23.56%
+11.3%
1Y
+52.60%
+32.6%
3Y
+88.02%
+13.9%
5Y
+214.49%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 1AE.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
10.63K
Total on file
Fundamentals
Market cap$54.66B
Enterprise value$49.83B
Revenue (TTM)$5.32B
Gross profit$3.14B
EBITDA$1.61B
Net income$1.72B
EPS (TTM)$22.50
Free cash flow$761.77M
Total cash$5.18B
Total debt$47.00M
Book value / share$115.17
Shares outstanding62.19M
Float62.43M
Short % of float—
Dividend yield—
Beta (5Y)-0.04
Valuation & profitability ratios
Trailing P/E39.07
Forward P/E—
PEG ratio1.61
Price / sales—
Price / book7.63
EV / revenue9.38
EV / EBITDA30.90
Gross margin59.07%
Operating margin31.99%
Profit margin32.27%
Return on equity23.64%
Return on assets11.63%
Debt / equity0.56
Current ratio5.12
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $4.15B | $2.19B | $1.23B | $410.75M | +89.6% |
| Operating revenue | $4.15B | $2.19B | $1.19B | $410.75M | +89.9% |
| Cost of revenue | $450.67M | $227.29M | $117.83M | $29.43M | +98.3% |
| Gross profit | $3.70B | $1.96B | $1.11B | $381.31M | +88.6% |
| Research & development | $1.36B | $983.42M | $859.49M | $663.37M | +38.7% |
| Selling, general & admin | $1.36B | $1.05B | $709.54M | $469.92M | +29.3% |
| Total operating expense | $2.65B | $1.98B | $1.53B | $1.11B | +33.7% |
| Operating income | $1.05B | -$17.84M | -$420.64M | -$723.92M | +6,010.2% |
| Net interest income | $159.01M | $155.04M | $106.48M | $22.55M | +2.6% |
| Pre-tax income | $1.28B | $85.18M | -$304.50M | -$729.31M | +1,401.1% |
| Tax provision | -$13.43M | -$747.86M | -$9.44M | -$19.72M | +98.2% |
| Net income | $1.29B | $833.04M | -$295.05M | -$709.59M | +55.1% |
| Net income to common | $1.29B | $833.04M | -$295.05M | -$709.59M | +55.1% |
| Basic EPS | 21.08 | 13.92 | -5.16 | -13.05 | +51.4% |
| Diluted EPS | 19.57 | 12.78 | -5.16 | -13.05 | +53.1% |
| EBIT | $1.28B | $87.64M | -$303.59M | -$727.12M | +1,363.5% |
| EBITDA | $1.31B | $105.17M | -$192.28M | -$622.78M | +1,146.3% |
| Basic shares | 61.30M | 59.86M | 57.17M | 54.38M | +2.4% |
| Diluted shares | 66.03M | 65.18M | 57.17M | 54.38M | +1.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $3.49B | $1.50B | $2.05B | $800.74M | +132.8% |
| Cash & short-term investments | $4.44B | $3.38B | $3.18B | $2.19B | +31.4% |
| Accounts receivable | $1.49B | $817.71M | $417.99M | $241.23M | +82.2% |
| Inventory | $473.53M | $407.23M | $310.55M | $228.35M | +16.3% |
| Total current assets | $6.90B | $4.88B | $4.12B | $2.77B | +41.3% |
| Property, plant & equipment | $48.25M | $43.52M | $22.68M | $16.23M | +10.9% |
| Goodwill & intangibles | $272.10M | $181.44M | $125.23M | $174.90M | +50.0% |
| Total assets | $8.68B | $6.20B | $4.54B | $3.13B | +40.0% |
| Total current liabilities | $1.32B | $669.92M | $422.99M | $302.28M | +97.1% |
| Total debt | $47.16M | $39.05M | $20.00M | $12.43M | +20.8% |
| Total liabilities | $1.36B | $704.24M | $444.95M | $320.56M | +93.1% |
| Retained earnings | -$279.77M | -$1.57B | -$2.40B | -$2.11B | +82.2% |
| Shareholder equity | $7.32B | $5.50B | $4.10B | $2.81B | +33.2% |
| Working capital | $5.58B | $4.21B | $3.70B | $2.47B | +32.4% |
| Net tangible assets | $7.05B | $5.32B | $3.97B | $2.64B | +32.6% |
| Shares issued | 61.88M | 60.76M | 59.19M | 55.40M | +1.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $1.05B | -$21.65M | -$425.05M | -$720.34M | +4,966.6% |
| Depreciation & amortisation | $28.10M | $17.53M | $111.31M | $104.34M | +60.3% |
| Stock-based compensation | $248.08M | $235.18M | $232.97M | $157.03M | +5.5% |
| Change in working capital | -$422.63M | -$325.17M | -$308.89M | -$375.72M | -30.0% |
| Operating cash flow | $685.19M | -$82.75M | -$420.33M | -$862.81M | +928.1% |
| Capital expenditure | -$111.68M | -$68.30M | -$43.81M | -$103.82M | -63.5% |
| Investing cash flow | $984.00M | -$717.59M | $308.21M | -$461.18M | +237.1% |
| Financing cash flow | $233.01M | $279.76M | $1.34B | $843.76M | -16.7% |
| Free cash flow | $573.51M | -$151.05M | -$464.14M | -$966.63M | +479.7% |
| End cash position | $3.49B | $1.50B | $2.05B | $800.74M | +132.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $1.51B | $1.30B | $1.29B | $1.13B | $947.96M | — | +16.7% |
| Operating revenue | $1.51B | $1.30B | $1.29B | $1.13B | $947.96M | — | +16.7% |
| Cost of revenue | $145.00M | $121.00M | $149.69M | $109.43M | $110.75M | — | +19.8% |
| Gross profit | $1.37B | $1.18B | $1.14B | $1.02B | $837.21M | — | +16.4% |
| Research & development | $486.00M | $443.00M | $371.71M | $355.65M | $327.70M | — | +9.7% |
| Selling, general & admin | $411.00M | $355.00M | $422.54M | $336.29M | $321.35M | — | +15.8% |
| Total operating expense | $876.00M | $783.00M | $778.63M | $667.57M | $633.37M | — | +11.9% |
| Operating income | $494.00M | $394.00M | $359.56M | $349.97M | $203.84M | — | +25.4% |
| Net interest income | $47.00M | $43.00M | $44.05M | $41.71M | $37.27M | — | +9.3% |
| Pre-tax income | $532.00M | $426.00M | $403.29M | $386.05M | $286.90M | — | +24.9% |
| Tax provision | $59.00M | $60.00M | -$129.66M | $41.80M | $41.54M | — | -1.7% |
| Net income | $472.00M | $366.00M | $532.95M | $344.26M | $245.36M | — | +29.0% |
| Net income to common | $472.00M | $366.00M | $532.95M | $344.26M | $245.36M | — | +29.0% |
| Basic EPS | — | 5.90 | — | — | — | 2.78 | — |
| Diluted EPS | — | 5.52 | — | — | — | 2.58 | — |
| EBIT | $533.00M | $427.00M | $404.12M | $387.05M | $288.02M | — | +24.8% |
| EBITDA | $533.00M | $427.00M | $404.12M | $387.05M | $288.02M | — | +24.8% |
| Basic shares | — | 62.06M | — | — | — | 60.98M | — |
| Diluted shares | — | 66.36M | — | — | — | 65.66M | — |
| Line item | 2026-06-30 | 2025-12-31 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $3.58B | $3.49B | $2.09B | $1.50B | +2.7% |
| Cash & short-term investments | $5.18B | $4.44B | $3.93B | $3.38B | +16.8% |
| Accounts receivable | $1.83B | $1.49B | $1.13B | $817.71M | +23.0% |
| Inventory | $371.00M | $473.53M | $340.62M | $407.23M | -21.7% |
| Total current assets | $8.07B | $6.90B | $5.83B | $4.88B | +16.9% |
| Property, plant & equipment | $52.00M | $48.25M | $45.80M | $43.52M | +7.8% |
| Goodwill & intangibles | $266.00M | $272.10M | $218.98M | $181.44M | -2.2% |
| Total assets | $10.03B | $8.68B | $7.18B | $6.20B | +15.5% |
| Total current liabilities | $1.57B | $1.32B | $1.04B | $669.92M | +19.3% |
| Total debt | $47.00M | $47.16M | $43.15M | $39.05M | -0.3% |
| Total liabilities | $1.61B | $1.36B | $1.08B | $704.24M | +18.8% |
| Retained earnings | $558.00M | -$279.77M | -$1.16B | -$1.57B | +299.5% |
| Shareholder equity | $8.42B | $7.32B | $6.10B | $5.50B | +14.9% |
| Working capital | $6.49B | $5.58B | $4.79B | $4.21B | +16.4% |
| Net tangible assets | $8.15B | $7.05B | $5.88B | $5.32B | +15.6% |
| Shares issued | 62.54M | 61.88M | 61.20M | 60.76M | +1.1% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $1.64B | +42.2% |
| Next quarter | — | — | $1.76B | +32.8% |
| Current year | — | — | $6.22B | +46.4% |
| Next year | — | — | $7.68B | +23.5% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.02%
Held by institutions48.05%
Institutions holding495
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
813.24
+8.09% from price
SMA 20
785.48
+11.91% from price
SMA 50
782.74
+12.30% from price
SMA 100
737.59
+19.17% from price
SMA 200
720.45
+22.01% from price
EMA 12
821.54
+6.99% from price
EMA 26
795.79
+10.46% from price
EMA 50
776.42
+13.21% from price
RSI (14)
67.0
Neutral
MACD (12,26,9)
25.75
Hist 14.89
ATR (14)
22.06
2.51% of price
Realised vol 30D
53.2%
Annualised
Bollinger upper
890.87
20, 2σ
Bollinger lower
680.09
20, 2σ
50 / 200 cross
Golden
782.74 vs 720.45
Trend bias
Above 200
+22.01%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.43
Less volatile than market
Correlation to SPY
0.14
Largely independent
Realised vol 30D
53.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-29.3%
Peak to trough
Max drawdown 5Y
-38.0%
Peak to trough
ATR 14
22.06
2.51% of price
Beta (reported)
-0.04
5Y monthly, from filing
Headlines
The “No-Contest Clause”: One Sentence That Makes Challenging Your Will Cost a Child Everything You Left Them.
24/7 Wall St. · 7m ago
Dow Jones Futures: Tariffs In Focus; Nvidia, Warsh Ahead
Investor's Business Daily · 14m ago
Nissan scrapped a bank it couldn't afford to build
TheStreet · 14m ago
Micron, Sandisk, and SK Hynix: History Says This About the Memory Trio's Rally
Motley Fool · 16m ago
Disney Adds Formula E to Disney+: Can Live Sports Strengthen its Streaming Business?
Insider Monkey · 17m ago
4-H rabbit show proves dedication of members
The Lima News, Ohio · 20m ago
Benz Announces A$150m Placement to Accelerate Delivery of Glenburgh Maiden Resource
TMX Newsfile · 21m ago
Abbott vs. Intuitive Surgical: Which MedTech Stock Offers Better Long-Term Upside?
Insider Monkey · 23m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.